These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30773626)

  • 21. Has molecular imaging delivered to drug development?
    Murphy PS; Patel N; McCarthy TJ
    Philos Trans A Math Phys Eng Sci; 2017 Nov; 375(2107):. PubMed ID: 29038381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Precision Medicine: precisely now.
    de Miguel-Yanes JM; Ezpeleta D
    Med Clin (Barc); 2018 Mar; 150(6):240-243. PubMed ID: 28743397
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacogenetics in the clinical analysis laboratory: clinical practice, research, and drug development pipeline.
    Miscio G; Paroni G; Bisceglia P; Gravina C; Urbano M; Lozupone M; Piccininni C; Prisciandaro M; Ciavarella G; Daniele A; Bellomo A; Panza F; Di Mauro L; Greco A; Seripa D
    Expert Opin Drug Metab Toxicol; 2019 Sep; 15(9):751-765. PubMed ID: 31512953
    [No Abstract]   [Full Text] [Related]  

  • 24. Breakthrough cancer genome analysis in time and space: novel oncotargets and early drug development.
    Kyrochristos ID; Ziogas DE; Antoniou P; Mitsis M; Lykoudis EG; Roukos DH
    Pharmacogenomics; 2018 Nov; 19(17):1303-1310. PubMed ID: 30348059
    [No Abstract]   [Full Text] [Related]  

  • 25. Organoids: the new kid in cancer research.
    Narasimhan V; Das A; Pham T; Wilson K; Kong J; Ramsay R; Heriot A
    ANZ J Surg; 2019 Oct; 89(10):1189-1190. PubMed ID: 31621167
    [No Abstract]   [Full Text] [Related]  

  • 26. The FNIH Biomarkers Consortium embraces the BEST.
    Menetski JP; Austin CP; Brady LS; Eakin G; Leptak C; Meltzer A; Wagner JA
    Nat Rev Drug Discov; 2019 Jul; 18(8):567-568. PubMed ID: 31367046
    [No Abstract]   [Full Text] [Related]  

  • 27. Flexibility in the FDA approach to orphan drug development.
    Hunter NL; Rao GR; Sherman RE
    Nat Rev Drug Discov; 2017 Nov; 16(11):737-738. PubMed ID: 28860647
    [No Abstract]   [Full Text] [Related]  

  • 28. Biopharmaceutical Drug Development Pillars: Begin With the End in Mind.
    Welch AR; Salomon R; Boroumand S
    Clin Pharmacol Ther; 2019 Jan; 105(1):33-35. PubMed ID: 30506670
    [No Abstract]   [Full Text] [Related]  

  • 29. Practical Assessment of Clinical Drug-Drug Interactions in Drug Development Using Physiologically Based Pharmacokinetics Modeling.
    Shebley M; Einolf HJ
    Clin Pharmacol Ther; 2019 Jun; 105(6):1326-1328. PubMed ID: 30893473
    [No Abstract]   [Full Text] [Related]  

  • 30. The right dose for every patient: a key step for precision medicine.
    Peck RW
    Nat Rev Drug Discov; 2016 Mar; 15(3):145-6. PubMed ID: 26669674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Next-generation sequencing in drug development: target identification and genetically stratified clinical trials.
    Doostparast Torshizi A; Wang K
    Drug Discov Today; 2018 Oct; 23(10):1776-1783. PubMed ID: 29758342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microphysiological Systems ("Organs-on-Chips") for Drug Efficacy and Toxicity Testing.
    Low LA; Tagle DA
    Clin Transl Sci; 2017 Jul; 10(4):237-239. PubMed ID: 28078768
    [No Abstract]   [Full Text] [Related]  

  • 33. Modelling human cardiac diseases with 3D organoid.
    Nugraha B; Buono MF; Emmert MY
    Eur Heart J; 2018 Dec; 39(48):4234-4237. PubMed ID: 30576473
    [No Abstract]   [Full Text] [Related]  

  • 34. [Developing the Next Generation Small-molecule Pharmaceuticals Using a Wide Variety of Elements].
    Fujii S; Ohta K
    Yakugaku Zasshi; 2022; 142(2):129-130. PubMed ID: 35110448
    [No Abstract]   [Full Text] [Related]  

  • 35. 2018 ASCO Presidential Address: "Delivering Discoveries: Expanding the Reach of Precision Medicine".
    Johnson BE
    J Clin Oncol; 2018 Oct; 36(29):2899-2903. PubMed ID: 30161020
    [No Abstract]   [Full Text] [Related]  

  • 36. Lessons for modern insulin development.
    Herring R; Russell-Jones DDL
    Diabet Med; 2018 Oct; 35(10):1320-1328. PubMed ID: 29802638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Digital phenotyping approaches and mobile devices enhance CNS biopharmaceutical research and development.
    Smith DG
    Neuropsychopharmacology; 2018 Dec; 43(13):2504-2505. PubMed ID: 30267015
    [No Abstract]   [Full Text] [Related]  

  • 38. Is precision medicine the future of healthcare?
    Barker RW
    Per Med; 2017 Nov; 14(6):459-461. PubMed ID: 29749853
    [No Abstract]   [Full Text] [Related]  

  • 39. World Molecular Imaging Congress 2015: precision medicine visualized.
    Manning HC
    Mol Imaging Biol; 2015 Jun; 17(3):295-6. PubMed ID: 25862478
    [No Abstract]   [Full Text] [Related]  

  • 40. Evidence-Based Precision Medicine is Needed to Move Toward General Internal Precision Medicine.
    Jaccard E; Cornuz J; Waeber G; Guessous I
    J Gen Intern Med; 2018 Jan; 33(1):11-12. PubMed ID: 28808923
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.